Morgan Stanley analyst Maxwell Skor downgraded Tscan Therapeutics Inc (NASDAQ: TCRX) from Overweight to Equalweight.The analyst commented, "Following TCRX’s recent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE